Works matching AU Helliwell, Philip S

Results: 122
    1
    2

    Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo‐Controlled DISCOVER‐1 Study

    Published in:
    ACR Open Rheumatology, 2023, v. 5, n. 3, p. 149, doi. 10.1002/acr2.11523
    By:
    • Ritchlin, Christopher T.;
    • Deodhar, Atul;
    • Boehncke, Wolf‐Henning;
    • Soriano, Enrique R.;
    • Kollmeier, Alexa P.;
    • Xu, Xie L.;
    • Zazzetti, Federico;
    • Shawi, May;
    • Jiang, Yusang;
    • Sheng, Shihong;
    • Helliwell, Philip S.
    Publication type:
    Article
    3
    4
    5

    The use of combination advanced therapies in psoriatic arthritis: results from a UK multi-centre audit Open Access.

    Published in:
    Rheumatology, 2025, v. 64, n. 5, p. 3173, doi. 10.1093/rheumatology/keaf037
    By:
    • Jethwa, Hannah;
    • Gudu, Tania;
    • Coates, Laura C;
    • Helliwell, Philip S;
    • Tillett, William;
    • Abuelmagd, Abdalla;
    • Andev, Rajinder S;
    • Ashraf, Madiha;
    • Baqai, Tanya;
    • Choy, Ernest;
    • Das, Dhivya;
    • Gullick, Nicola;
    • Heighton, Catherine;
    • Kinder, Alison;
    • Laxminarayan, Ramasharan;
    • Mittal, Gayatri;
    • Morris, Penelope;
    • Mukherjee, Sandeep;
    • Nandagudi, Anupama;
    • Rangaraj, Satyapal
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1).

    Published in:
    Rheumatology, 2020, v. 59, n. 10, p. 2774, doi. 10.1093/rheumatology/kez684
    By:
    • Chandran, Vinod;
    • Heijde, Désirée van der;
    • Fleischmann, Roy M;
    • Lespessailles, Eric;
    • Helliwell, Philip S;
    • Kameda, Hideto;
    • Burgos-Vargas, Ruben;
    • Erickson, Janelle S;
    • Rathmann, Suchitrita S;
    • Sprabery, Aubrey Trevelin;
    • Birt, Julie A;
    • Shuler, Catherine L;
    • Gallo, Gaia
    Publication type:
    Article
    12
    13
    14
    15

    Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis.

    Published in:
    Rheumatology, 2017, v. 56, n. 4, p. 603, doi. 10.1093/rheumatology/kew433
    By:
    • Tillett, William;
    • Shaddick, Gavin;
    • Jobling, Amelia;
    • Askari, Ayman;
    • Cooper, Annie;
    • Creamer, Paul;
    • Clunie, Gavin;
    • Helliwell, Philip S.;
    • James, Jana;
    • Kay, Lesley;
    • Korendowych, Eleanor;
    • Lane, Suzanne;
    • Packham, Jonathon;
    • Shaban, Ragai;
    • Thomas, Matthew L.;
    • Williamson, Lyn;
    • McHugh, Neil
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative.

    Published in:
    Rheumatology Advances in Practice, 2020, v. 4, n. 2, p. 1, doi. 10.1093/rap/rkaa032
    By:
    • Marco, Gabriele De;
    • Berekméri, Anna;
    • Coates, Laura C;
    • Dubash, Sayam;
    • Emmel, Jenny;
    • Gladman, Dafna D;
    • Lubrano, Ennio;
    • McGonagle, Dennis G;
    • Mahmood, Farrouq;
    • Marchesoni, Antonio;
    • Mason, Laura;
    • Ogdie, Alexis;
    • Wittmann, Miriam;
    • Helliwell, Philip S;
    • Marzo-Ortega, Helena
    Publication type:
    Article
    23

    Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting.

    Published in:
    Journal of Rheumatology, 2018, v. 45, p. 54, doi. 10.3899/jrheum.180141
    By:
    • Jadon, Deepak R.;
    • Chandran, Vinod;
    • Stober, Carmel;
    • Ogdie, Alexis;
    • Armstrong, April W.;
    • Duffin, Kristina Callis;
    • Gladman, Dafna D.;
    • Helliwell, Philip S.;
    • O'Sullivan, Denis;
    • de Wit, Maarten;
    • FitzGerald, Oliver;
    • Ritchlin, Christopher T.
    Publication type:
    Article
    24
    25
    26

    GRAPPA 2016 Project Report.

    Published in:
    2017
    By:
    • Helliwell, Philip S.;
    • FitzGerald, Oliver;
    • Coates, Laura C.;
    • Duffin, Kristina Callis;
    • Mease, Philip J.;
    • Callis Duffin, Kristina
    Publication type:
    journal article
    27
    28
    29
    30
    31
    32
    33
    34

    GRAPPA 2015 Research and Education Project Reports.

    Published in:
    2016
    By:
    • Mease, Philip J.;
    • Helliwell, Philip S.;
    • Boehncke, Wolf-Henning;
    • Coates, Laura C.;
    • FitzGerald, Oliver;
    • Gladman, Dafna D.;
    • Deodhar, Atul A.;
    • Duffin, Kristina Callis;
    • Callis Duffin, Kristina
    Publication type:
    journal article
    35
    36
    37
    38

    Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling.

    Published in:
    Arthritis & Rheumatology, 2022, v. 74, n. 9, p. 1535, doi. 10.1002/art.42154
    By:
    • Soomro, Mehreen;
    • Stadler, Michael;
    • Dand, Nick;
    • Bluett, James;
    • Jadon, Deepak;
    • Jalali‐najafabadi, Farideh;
    • Duckworth, Michael;
    • Ho, Pauline;
    • Marzo‐Ortega, Helena;
    • Helliwell, Philip S.;
    • Ryan, Anthony W.;
    • Kane, David;
    • Korendowych, Eleanor;
    • Simpson, Michael A.;
    • Packham, Jonathan;
    • McManus, Ross;
    • Gabay, Cem;
    • Lamacchia, Céline;
    • Nissen, Michael J.;
    • Brown, Matthew A.
    Publication type:
    Article
    39
    40

    Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.

    Published in:
    Arthritis & Rheumatology, 2016, v. 68, n. 5, p. 1060, doi. 10.1002/art.39573
    By:
    • Coates, Laura C.;
    • Kavanaugh, Arthur;
    • Mease, Philip J.;
    • Soriano, Enrique R.;
    • Laura Acosta‐Felquer, Maria;
    • Armstrong, April W.;
    • Bautista‐Molano, Wilson;
    • Boehncke, Wolf‐Henning;
    • Campbell, Willemina;
    • Cauli, Alberto;
    • Espinoza, Luis R.;
    • FitzGerald, Oliver;
    • Gladman, Dafna D.;
    • Gottlieb, Alice;
    • Helliwell, Philip S.;
    • Husni, M. Elaine;
    • Love, Thorvardur J.;
    • Lubrano, Ennio;
    • McHugh, Neil;
    • Nash, Peter
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response—results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis.

    Published in:
    Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02554-3
    By:
    • Rahman, Proton;
    • Mease, Philip J.;
    • Helliwell, Philip S.;
    • Deodhar, Atul;
    • Gossec, Laure;
    • Kavanaugh, Arthur;
    • Kollmeier, Alexa P.;
    • Hsia, Elizabeth C.;
    • Zhou, Bei;
    • Lin, Xiwu;
    • Shawi, May;
    • Karyekar, Chetan S.;
    • Han, Chenglong
    Publication type:
    Article
    47
    48
    49

    Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study.

    Published in:
    Patient, 2022, v. 15, n. 6, p. 657, doi. 10.1007/s40271-022-00588-6
    By:
    • Orbai, Ana-Maria;
    • Coates, Laura C.;
    • Deodhar, Atul;
    • Helliwell, Philip S.;
    • Ritchlin, Christopher T.;
    • Leibowitz, Evan;
    • Kollmeier, Alexa P.;
    • Hsia, Elizabeth C.;
    • Xu, Xie L.;
    • Sheng, Shihong;
    • Jiang, Yusang;
    • Liu, Yan;
    • Han, Chenglong
    Publication type:
    Article
    50